LTBR gene

Last updated on: 04.05.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The LTBR gene (LTBR stands for lymphotoxin beta receptor) is a protein-coding gene located on chromosome 12p13.31. The LTBR gene encodes a member of the tumor necrosis factor receptor superfamily, namely the "lymphotoxin beta receptor(CD18)". Alternatively spliced transcript variants encoding multiple isoforms have been observed.

General informationThis section has been translated automatically.

The most important ligands of this receptor include lymphotoxin alpha/beta and tumor necrosis factor ligand superfamily member 14. The encoded protein plays a role in signal transduction during lymphoid and other organ development, lipid metabolism, immune response and programmed cell death (promotes apoptosis via TRAF3 and TRAF5). The activity of this receptor has also been linked to carcinogenesis.

Diseases associated with LTBR include basal cell carcinoma of the pinna and squamous cell carcinoma of the pinna. Related pathways include TNF Superfamily - Human Ligand-Receptor Interactions and their Associated Functions and LT-BetaR Pathway. Gene Ontology (GO) annotations related to this gene include Identical protein binding and Ubiquitin-protein ligase binding. An important paralog of this gene is TNFRSF11A.

LiteratureThis section has been translated automatically.

  1. Navrazhina K et al. (2020) Basal cell carcinomas of the ear are more aggressive and have higher discordance rates between biopsy and Mohs histopathology. J Am Acad Dermatol 83(6):1805-1807

Last updated on: 04.05.2024